-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
RECURSION PHARMACEUTICALS, INC. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2019 to Q1 2025.
- RECURSION PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$132M, a 29% decline year-over-year.
- RECURSION PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$359M, a 24.8% decline from 2023.
- RECURSION PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$288M, a 245% decline from 2022.
- RECURSION PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$83.5M, a 47.3% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)